Patrick David Lopath

This inventor holds 24 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 15 EPO patents, primarily in Corneal Treatment Technology. Top assignees: Teclens, LLC, Prorhythm, Inc., Transurgical, Inc.. Active years: 2003-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick David Lopath. Retrieved from https://idiyas.com/inventor/patrick-david-lopath

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 7)

% Patents Active = 79.2

CIPO Patents = 3

EPO Patents = 15 (Patent Applications = 13)

Average Co-Inventor Count = 2.7

ph-index = 13

Forward Citations = 2,789(Granted Patents)

Location History:

East Setauket, NY (US) (2003)
Setauket, NY (US) (2003 - 2004)
Rocky Point, NY (US) (2006)
Durham, NC (US) (2004 - 2010)
Stamford, CT (US) (2007 - 2021)

Company Filing History:

Oriel Therapeutics, Inc.

Years Active: 2003-2021

Loading Chart...

Areas of Expertise:

Corneal Crosslinking

Acoustic Dosimetry

Phototherapy

Dry Powder Inhalers

Cardiac Ablation

Ultrasound Transducers

Thermal Treatment

Inflatable Lens

Energy Application

Intrabody Treatment

Balloon Alignment

Agglomeration Inhibition

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11020608 - Corneal measurement and control of corneal crosslinking (2021-06-01),

2. 10925771 - Device for irradiation of the eye (2021-02-23),

3. 10548773 - Programmable patterning and masking array for corneal collagen crosslinking (2020-02-04),

4. 10548772 - Real time acoustic dosimetry for corneal collagen crosslinking (2020-02-04),

5. 10010449 - Corneal crosslinking with oxygenation (2018-07-03),

6. 9907698 - Apparatus for phototherapy of the eye (2018-03-06),

7. 9883970 - Real time acoustic dosimetry for corneal collagen crosslinking (2018-02-06),

8. 9861526 - Programmable patterning and masking array for corneal collagen crosslinking (2018-01-09),

9. 9339616 - Dry powder inhalers (2016-05-17),

10. 9027551 - Dry powder inhalers that inhibit agglomeration, related devices and methods (2015-05-12),

11. 8365725 - Dry powder inhalers that inhibit agglomeration, related devices and methods (2013-02-05),

12. 8210171 - Tubular dry powder drug containment systems, associated inhalers and methods (2012-07-03),

13. 7837676 - Cardiac ablation devices (2010-11-23),

14. 7540846 - Energy application with inflatable annular lens (2009-06-02),

15. 7326201 - Thermal treatment methods and apparatus with focused energy application (2008-02-05),

Patrick David Lopath: Innovator in Corneal Technology

Introduction

Patrick David Lopath, based in Stamford, Connecticut, is a distinguished inventor known for his significant contributions to corneal measurement and treatment technologies. With a remarkable portfolio of 24 patents, Lopath has dedicated his career to advancing eye care through innovative solutions.

Latest Patents

Lopath's latest inventions showcase his focus on corneal health. One of his notable patents involves systems and methods for monitoring properties of the cornea and controlling the crosslinking treatment. This innovation utilizes ultrasonic reflections to measure the thickness of the cornea during crosslinking by determining anterior and posterior distances between various eye surfaces. The derived measurements help assess the speed of sound in the cornea, enabling real-time monitoring of the treatment's effectiveness. Furthermore, another patent describes a device designed for the irradiation of the eye using light, particularly UV light, which is essential in the corneal crosslinking process.

Career Highlights

Throughout his career, Lopath has been associated with companies such as Teclens, LLC and Prorhythm, Inc., where he has played pivotal roles in developing cutting-edge technologies. His expertise in the field of ophthalmology has solidified his reputation as an innovator who constantly pushes the boundaries of medical technology.

Collaborations

Lopath has collaborated with esteemed colleagues, including David E. Acker and Edward Paul Harhen. These partnerships have fostered an environment of innovation and have significantly contributed to the advancements made in corneal treatment technologies.

Conclusion

Patrick David Lopath stands out as a forward-thinking inventor whose work has the potential to transform the field of ophthalmology. His dedication to developing systems for improving corneal health demonstrates the impactful role inventors play in enhancing medical treatments and outcomes.

Profile summary based on public USPTO records.